SCHEMBL2398455

SCHEMBL2398455

CCc1ccc(-c2nc3c(o2)C(=O)C(OC)=CC3=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.41
TDP2 O95551 1/20 0.39
NSD2 O96028 1/20 0.39
USP1 O94782 3/20 0.38
USP19 O94966 2/20 0.38
WDR48 Q8TAF3 1/20 0.38
UCHL3 P15374 1/20 0.38
IDO1 P14902 3/20 0.37
MAPT P10636 7/20 0.36
RAB9A P51151 4/20 0.36
TP53 P04637 4/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
TARBP2 Q15633 2/20 0.36
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN5 P54829 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1917683 0.75 CDC25A (0.61) NOTUMUSP1USP19WDR48UCHL3
SCHEMBL2401246 0.73 CDC25A (0.49) NOTUMUSP1USP19WDR48UCHL3
SCHEMBL2401248 0.71 NPSR1 (0.35) NOTUMTDP2USP1USP19WDR48
SCHEMBL1917840 0.71 MEN1 (0.45) MAPTRAB9ATP53NPC1SMN1; SMN2
SCHEMBL2402102 0.71 CDC25A (0.60) TDP2NSD2USP1USP19WDR48
SCHEMBL1917209 0.68 CDC25A (0.51) NOTUMUSP1USP19WDR48UCHL3
SCHEMBL7808315 0.63 USP1 (0.71) USP1USP19WDR48UCHL3MAPT
SCHEMBL9627961 0.62 CDC25B (0.57) TDP2NSD2IDO1MAPTRAB9A
SCHEMBL4859215 0.61 CDC25A (0.52) TDP2NSD2USP1USP19WDR48
SCHEMBL10062469 0.61 NOTUM (0.55) NOTUMMAPTRAB9ATP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017637-B2 Inhibitors of cdc phosphatases IPSEN PHARMA S.A.S. (FR) 2011-09-13 US disclosed
US-20090275624-A1 INHIBITORS OF CDC PHOSPHATASES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-11-05 US disclosed
EP-1831209-B1 CDC25 PHOSPHATASE INHIBITORS IPSEN PHARMA (FR) 2009-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275624-A1 INHIBITORS OF CDC PHOSPHATASES CDC25C, CDC25A, CDC25B NOTUM 2577/4885TDP2 922/4885NSD2 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.